PVCT · Provectus Biopharmaceuticals, Inc. · Exempt Offerings
$0.05
+0.00 (+0.00%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The aforementioned factors indicate that management's plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$21.01M
Shares
420.28M
Volume · Oct 21
20.1K
Avg daily vol (3M)
123.61K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.